Nutrition.ad Nutrition.ad
Nutrition News

Whole grains gain traction with consumers as evidence links intake to lower cardiometabolic risk

Survey data show breakfast is the top occasion for whole grain intake, while recent reviews and long-running cohort studies continue to associate whole grains with lower cardiovascular risk and mortality.

Whole grains gain traction with consumers as evidence links intake to lower cardiometabolic risk
#whole grains#heart health#type 2 diabetes#metabolic health#diet research#nutrition study#cardiovascular risk#inflammation markers

Whole grains gain traction with consumers as evidence links intake to lower cardiometabolic risk

U.S. consumers report actively seeking whole-grain foods—most often at breakfast—amid a growing body of peer-reviewed research associating higher whole-grain intake with lower cardiovascular risk, improved cardiometabolic markers and reduced mortality.

In a consumer study reported by Food Business News, breakfast was cited as the leading mealtime for whole-grain consumption (48% of respondents), followed by dinner (34%), lunch (31%) and snack times (22%). The survey snapshot underscores how whole grains are showing up in daily eating patterns even as public-health researchers continue to examine their links to long-term outcomes.

Clinical evidence: cardiovascular disease and mortality associations

Large prospective cohort research in the U.S. has repeatedly connected whole-grain intake with lower death rates, particularly from cardiovascular causes. In two large prospective studies of U.S. men and women, higher whole-grain consumption was inversely associated with all-cause mortality and especially cardiovascular disease (CVD) mortality, with analyses also pointing to the bran component as a significant contributor, according to the paper published in JAMA Internal Medicine and archived at the U.S. National Library of Medicine.

Earlier findings highlighted by Atrium Health Wake Forest Baptist similarly emphasized the magnitude of the association: lead author Philip Mellen, M.D., said consuming an average of 2.5 servings of whole grains per day was associated with a 21% lower risk of cardiovascular disease compared with much lower intake, in an institutional news release summarizing the research.

Meta-analyses and umbrella reviews: metabolic, lipid and inflammation signals

Beyond observational cohorts, recent evidence syntheses have focused on intermediate cardiometabolic outcomes evaluated in randomized controlled trials (RCTs) and systematic reviews.

An umbrella review in Food & Function (RSC Publishing) aggregated systematic reviews and meta-analyses of RCTs across a wide range of outcomes—spanning diabetes-related measures, lipid metabolism, anthropometrics, blood pressure and inflammatory markers—reflecting continued scientific attention to whether whole grains affect clinically relevant biomarkers.

Inflammation has been a key area of interest because chronic low-grade inflammation is implicated in cardiometabolic disease pathways. A meta-analysis of 13 RCTs (466 participants) indexed on PubMed reported that whole-grain consumption was associated with a reduction in high-sensitivity C-reactive protein (hs-CRP), an inflammation marker often used in clinical research. A separate systematic review in Nutrients found the overall trial evidence suggested a downregulation of inflammation, while also noting variability in the types of foods classified as “whole grain” across interventions.

Diabetes and blood pressure: risk estimates from prospective evidence

Recent syntheses have also examined dose-response relationships and longer-term risk.

A 2024 systematic review and dose-response meta-analysis in Nutrition Journal reported probable benefits of whole grains for glycemic control, with prospective cohort summaries indicating that 50 grams/day of whole-grain ingredients was associated with a 25% relative risk reduction for type 2 diabetes.

In 2025, a meta-analysis in Scientific Reports found higher whole-grain intake was associated with a lower risk of hypertension (summary relative risk 0.74 for high vs. low intake), while refined grain intake did not show a similarly clear association in the same analysis.

Intake gaps and population patterns remain a focus

While U.S. consumer survey results suggest interest and routine use—especially at breakfast—population-level intake remains an ongoing research focus across North America.

Research presented at the Canadian Nutrition Society annual conference and later published in PLOS ONE, summarized by General Mills, examined Canadian whole-grain intake patterns and contributed to a broader understanding of how intake varies across populations and demographic groups.

Meanwhile, the Whole Grains Council has highlighted research syntheses reviewing RCT evidence and cardiometabolic outcomes, reflecting ongoing efforts by nutrition-focused organizations to translate research into public-facing summaries of what is known—and where evidence is still developing.

References & Links

Back to News